Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 91

Results For "ISA"

1072 News Found

Covaxin shelf-life extended to 12 months from the date of manufacture
News | November 03, 2021

Covaxin shelf-life extended to 12 months from the date of manufacture

This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO


SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
Digitisation | November 02, 2021

SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers

New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation


Glamyo Health widens its dental treatment portfolio
Startup | November 01, 2021

Glamyo Health widens its dental treatment portfolio

Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth


EMA encourages companies to submit type I variations by end- November
Policy | November 01, 2021

EMA encourages companies to submit type I variations by end- November

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021


GlaxoSmithKline posts Q2FY22 consolidated PAT at  Rs. 204.24 Cr
News | November 01, 2021

GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021


Indian Pharma Market witnesses rise in volumes and prices in September.
News | October 28, 2021

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.


Novartis receives priority review by U.S. FDA and filing acceptance by EMA for Kymriah
Biotech | October 28, 2021

Novartis receives priority review by U.S. FDA and filing acceptance by EMA for Kymriah

Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications


WHO selects Medigen’s Covid-19 vaccine for solidarity trial
Biotech | October 27, 2021

WHO selects Medigen’s Covid-19 vaccine for solidarity trial

Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial


4baseCare partners with U.S. based Cellworks for personalised cancer care
Digitisation | October 27, 2021

4baseCare partners with U.S. based Cellworks for personalised cancer care

The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.


Biocon Q2FY22 in line with estimates, better margins: ICICI Direct
News | October 25, 2021

Biocon Q2FY22 in line with estimates, better margins: ICICI Direct

Key takeaways of recent quarter & conference call highlights